Literature DB >> 4079592

Edemagenic activity of aqueous form of muramyl dipeptide (MDP) in rats.

Z Zídek, K Masek.   

Abstract

Repeated systemic administration of MDP in saline has been found to produce dose-dependent edema of paws in rats. Two to three daily doses are sufficient to induce significant increase of the paw volume. The edema is spontaneously well reversible. Its formation may substantially be reduced by indomethacin or prednisone, suggesting thus an involvement of prostaglandins. Body-weight loss and impaired walking of animals were also observed. Severity of all the effects was found to be markedly dependent on the strain of rats used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4079592

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  3 in total

Review 1.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

2.  Some cellular and pathophysiological correlates of the inflammatory effects of a synthetic immunomodulatory agent, muramyl dipeptide (MDP).

Authors:  Z Zídek; D Franková; K Masek
Journal:  Agents Actions       Date:  1993-01

3.  Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.

Authors:  Z Zídek
Journal:  Agents Actions       Date:  1992-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.